Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Novartis to acquire Myricx Bio in up to $1.5bn deal

Jul 6, 2026, 10:08 AM

Read Full Article → Novartis to acquire Myricx Bio in up to $1.5bn deal

Novartis to acquire Myricx Bio in up to $1.5bn deal

Translate article text

Choose a language and wait for the translated text.

Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.

Novartis to acquire Myricx Bio in up to $1.5bn deal | PharmaVoice